CAG
AGIO icon

Crestwood Advisors Group’s Agios Pharmaceuticals AGIO Stock Holding History

Crestwood Advisors Group’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-1,233
Closed -$58K – 166
2017
Q1 		$58K Buy
+1,233
New +$59.1K 0.01% 238

Other funds holding AGIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Crestwood Advisors Group's AGIO Position: Q2 2017 in Review

Crestwood Advisors Group sold out of Agios Pharmaceuticals (AGIO) in Q2 2017, closing a stake of 1,233 shares — an estimated $58K sold.

Crestwood Advisors Group first reported a position in AGIO in Q1 2017 and held it in 1 quarter. The position peaked at $58K in Q1 2017. 167 funds tracked by Wall St. Rank hold AGIO as of Q2 2017.

  • Crestwood Advisors Group reported no remaining Agios Pharmaceuticals position as of Q2 2017 after selling out during the quarter.
  • Crestwood Advisors Group sold 1,233 Agios Pharmaceuticals shares in Q2 2017, an estimated $58K.
  • Crestwood Advisors Group first reported a position in Agios Pharmaceuticals in Q1 2017 and held it in 1 quarter.
  • Crestwood Advisors Group's Agios Pharmaceuticals position peaked at $58K in Q1 2017.
  • 167 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2017.

Based on Crestwood Advisors Group's 13F filing for Q2 2017, filed 31 Jul 2017.